Documents
Resources
Learning Center
Upload
Plans & pricing Sign in
Sign Out

IMARC Group Releases the Most Comprehensive Report on the Global Biopharmaceutical Market

VIEWS: 14 PAGES: 4

Driven by their target oriented nature that enables them to attack only the diseased cells without affecting the healthy ones, biopharmaceuticals today represent one of the fastest growing segments of the pharmaceutical industry.

More Info
									IMARC Group Releases the Most Comprehensive Report on the
Global Biopharmaceutical Market



Driven by their target oriented nature that enables them to attack only the diseased cells
without affecting the healthy ones, biopharmaceuticals today represent one of the
fastest growing segments of the pharmaceutical industry.




Since they were launched three decades ago, biologicals have grown in importance as
they offer hope for people with severe and life-threatening indications for which there
was earlier no treatment or cure. Biopharmaceuticals today represent one of the fastest
growing segments of the pharmaceutical industry, with more than 300 products on the
market and over 500 expected to be in research and development.


Research firm IMARC Group expects this market to grow at a CAGR of around 8.2%
during 2011-2017, according to its latest report titled “Global Biopharmaceutical
Market Report & Forecast (2012-2017)”. The report which has done a comprehensive
analysis of all major developed and emerging biopharmaceutical markets expects
biologicals to account for nearly 15% of the global pharmaceutical market by 2017.
According to an analyst at IMARC Group, “a major advantage of biopharmaceuticals is
that they can be tailored as per the individual needs of a patient. This enables
biopharmaceuticals to be target oriented and highly specific in nature. The target
oriented nature of biopharmaceuticals enables them to attack only the diseased cells
without affecting the healthy ones. This results in lower side effects and a very high
efficacy”.


IMARC’s new report “Global Biopharmaceutical Market Report & Forecast (2012-
2017)” gives a deep insight into the global biopharmaceutical market. The research
study serves as an analytical as well as a statistical tool to understand the strengths,
weaknesses, opportunities, threats, market trends, geographical structure, therapeutic
structure, competitive structure and the outlook of the global biopharmaceutical market
till 2017. This report will serve as an excellent guide for investors, researchers,
consultants, marketing strategists, and all those who are planning to foray into the
global biopharmaceutical market in any form.


What We Have Achieved in this Report?


Deep Qualitative Understanding of Various Factors Driving and Restraining the
Global Biopharmaceutical Market
Key Aspects Analyzed:
      Driving Factors
      Restraining Factors
      Market Opportunities
      Threats


Comprehensive Situation Analysis of the Global Biopharmaceutical Market and
its Dynamics
Regions/Countries Covered:
North America: United States and Canada
Latin America: Mexico, Brazil and Argentina
Europe: Germany, France, Italy, Spain, United Kingdom, Russia and Turkey
Asia Pacific: Japan, China, Australia, South Korea, India and Indonesia


Classes Covered for Each Country: Erythropoietins, Insulin, Interferons, Growth
Hormones, Immunoglobulins, Colony Stimulating Factors, Recombinant Blood Factors,
Recombinant Enzymes, Growth Factors, Interleukins, Monoclonal Antibodies and
Purified Proteins


Focus of the Analysis for Each Country:
      Total Market Performance (2005 - 2011)
      Performance of Various Classes (2005 - 2011)
      Performance of Top Players (2005 - 2011)
      Market Forecast (2012 - 2017)


Key Questions Answered in this Report:
      What are the key advantages/ disadvantages of biopharmaceuticals over small
       molecule drugs in terms of efficacy, safety, price, approval times, market growth,
       etc.?

       What are the key opportunities and threats faced by the biopharmaceutical
       industry?

      What has been the historical and current performance of the global
       biopharmaceutical market and how is it expected to perform in the coming years?

      Which are the world’s largest biopharmaceutical markets?

      Which are the world’s fastest growing biopharmaceutical markets?

      What is the structure and composition of various biopharmaceutical markets
       across the globe?

      Which are the world’s largest biopharmaceutical segments?

      Which are the world’s fastest growing biopharmaceutical segments?

      Who are the world’s largest biopharmaceutical companies and how have they
       performed in recent years?




To buy the complete report or to get a free sample, please contact:

IMARC Group Asia
Email: apac@imarcgroup.com
Phone: +91-120-415-5099


IMARC Group North America
Email: america@imarcgroup.com
Phone: +1-631-791-1145

IMARC Group Europe, Middle East & Africa
Email:ema@imarcgroup.com
Phone: +44-702-409-7331

To know more please visit: http://www.imarcgroup.com/global-biopharmaceutica-
market-report-forecasts-2012-2017/




Keywords:
Biopharmaceuticals market, Global Biopharmaceuticals market, Pharmaceuticals market, Recombinant proteins market, Monoclonal
anti-bodies market, Purified Proteins market

								
To top